FORM OF CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • December 17th, 2018 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
FOR VALUE RECEIVED, RESPIRERX PHARMACEUTICALS INC., a Delaware corporation (“RespireRx” or the “Borrower”), with a mailing address at 126 Valley Road, Suite C, Glen Rock, New Jersey 07452, hereby promises to pay, unless previously converted, on the earlier of the business day following the first closing of the next exempt private securities offering of RespireRx, or, if not converted or repaid earlier, then on February 28, 2019 (the “Final Maturity Date”), and to the order of [___Name of lender__] (the “Lender”), with an address of [___Address of lender___], or at such other place as the holder hereof may designate in writing, the principal sum of [__Amount in words ] Dollars ($[_Amount in numbers__]), together with interest thereon at the interest rate as set forth herein (the “Loan”). The Lender’s books and records as to amounts due under this Note shall be conclusive absent manifest error.
